HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susceptibility to seizures produced by chemical convulsants and maximal electric shock in rats after electrolytic lesions into the red nucleus.

Abstract
Bilateral electrolytic lesions into the red nucleus (RN) of rat elicit an increase in susceptibility to seizures induced by pilocarpine, kainic acid, isoniazid, pentylenetetrazole, bicuculline and maximal electric shock (MES). It was also observed that carbachol-induced wet-dog shakes were increased in the RN-lesioned rats. The brain acetylcholine (ACh) and gamma-aminobutyric acid (GABA) concentrations were significantly decreased in the striatum and substantia nigra, respectively. There were no changes in electroencephalogram (EEG) recordings in the RN-lesioned group compared with sham-operated rats. Based on the results it is proposed that the RN is involved in the generalization and acceleration of seizure activity through the cholinergic and GABA-ergic system.
AuthorsK Kolasa, Z Kleinrok, S Consolo, P Ferrario, L Zecca
JournalPharmacology, biochemistry, and behavior (Pharmacol Biochem Behav) Vol. 41 Issue 1 Pg. 99-103 (Jan 1992) ISSN: 0091-3057 [Print] United States
PMID1539084 (Publication Type: Journal Article)
Chemical References
  • Convulsants
  • gamma-Aminobutyric Acid
  • Carbachol
  • Acetylcholine
Topics
  • Acetylcholine (metabolism)
  • Animals
  • Brain Chemistry (drug effects)
  • Carbachol (toxicity)
  • Convulsants (toxicity)
  • Electroencephalography
  • Electroshock
  • Epilepsy, Tonic-Clonic (chemically induced, physiopathology)
  • Male
  • Rats
  • Rats, Inbred Strains
  • Red Nucleus (physiology)
  • Seizures (chemically induced, physiopathology)
  • gamma-Aminobutyric Acid (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: